These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5058799)

  • 1. Impaired lymphocyte response to allogeneic cultured lymphoid cells in patients with lung cancer.
    Han T; Takita H
    N Engl J Med; 1972 Mar; 286(11):605-6. PubMed ID: 5058799
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological studies in bronchogenic carcinoma].
    Zeromski J
    Pol Tyg Lek; 1973 May; 28(22):836-8. PubMed ID: 4722196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic detection of bronchial cancer?].
    Muhrer KH; Effenhauser P; Pasurka B
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():995-7. PubMed ID: 6647382
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
    Han T; Takita H
    Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of different plasmas on the behavior of blastization of lymphocytes from patients with pulmonary neoplasms (preliminary note)].
    Pozzi E; Serra R; Menghini P
    Riv Emoter Immunoematol; 1971; 18(1):43-50. PubMed ID: 5164574
    [No Abstract]   [Full Text] [Related]  

  • 6. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
    Hadjipetrou-Kourounakis L; Tsougranis A
    Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives in immunotherapy of lung cancer.
    Hersh EM; Gutterman JU; Mavligit GM
    Cancer Treat Rev; 1974 Mar; 1(1):65-80. PubMed ID: 4471091
    [No Abstract]   [Full Text] [Related]  

  • 8. Demonstration of immune reactions against cultured hamartoma cells with lymphocytes from patients with bronchogenic carcinoma.
    Pierce GE; Allingham R; Bell JW
    Surg Forum; 1972; 23(0):89-91. PubMed ID: 4671035
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of radiotherapy on lymphocyte cytotoxicity against allogeneic lung cancer cells in patients with bronchogenic carcinoma.
    Toyohira K; Yasumoto K; Manabe H; Ohta M; Terashima H; Takayama K; Shinohara S; Nomoto K
    Gan; 1979 Feb; 70(1):9-14. PubMed ID: 446978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprofile studies for patients with bronchogenic carcinoma--I: correlation of pre-therapy studies with stage of diseases.
    Concannon JP; Dalbow MH; Eng CP; Conway J
    Int J Radiat Oncol Biol Phys; 1977; 2(5-6):447-54. PubMed ID: 301875
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytotoxic activity of lymphocytes to bronchogenic carcinoma cells in patients with lung cancer.
    Yasumoto K; Ohta M; Nomoto K
    Gan; 1976 Aug; 67(4):505-11. PubMed ID: 1030675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immunity in neoplasia. Antigen and mitogen responses in patients with bronchiogenic carcinoma.
    Rees JC; Rossio JL; Wilson HE; Minton JP; Dodd MC
    Cancer; 1975 Dec; 36(6):2010-5. PubMed ID: 173458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
    Alsabti EA
    Oncology; 1979; 36(4):171-5. PubMed ID: 157453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocompetence of patients with bronchogenic carcinoma.
    Olkowski ZL; McLaren JR; Mansour KA
    Ann Thorac Surg; 1976 Jun; 21(6):546-51. PubMed ID: 179484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte mitogen stimulation studies for patients with lung cancer: evaluation of prognostic significance of preirradiation therapy studies.
    Dalbow MH; Concannon JP; Eng CP; Weil CS; Conway J; Narayanan Nambisan PT
    J Lab Clin Med; 1977 Aug; 90(2):295-302. PubMed ID: 886214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of immune responses to tumors using cryostat sections of bronchogenic carcinoma.
    Erickson AD
    Cancer Res; 1980 Oct; 40(10):3598-3601. PubMed ID: 7002290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.
    Brugarolas A; Han T; Takita H; Minowada J
    N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical relevancy of cellular immunity in bronchogenic carcinoma].
    Muhrer KH; Filler D; Schwemmle K; Gierhake FW
    Prax Klin Pneumol; 1982 Aug; 36(8):335-9. PubMed ID: 7134160
    [No Abstract]   [Full Text] [Related]  

  • 19. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
    Zhukhina GE
    Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunologic status of patients with bronchogenic carcinoma of the lung].
    Rowińska-Zakrzewska E; Byszewska D; Grubek-Jaworska H; Zabuska-Jabłońska K; Plucińska M
    Pneumonol Pol; 1979 Apr; 47(4):221-30. PubMed ID: 313046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.